BioCentury
ARTICLE | Clinical News

FDA approves Hologic's Aptima HSV 1 & 2 assay

June 22, 2017 11:31 PM UTC

FDA approved the Aptima HSV 1 & 2 assay from Hologic Inc. (NASDAQ:HOLX) to diagnose and differentiate HSV-1 and HSV-2 infection. The in vitro nucleic acid amplification test is designed to run on the...

BCIQ Company Profiles

Hologic Inc.